Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ATECNASDAQ:LCAPNASDAQ:LMATNASDAQ:PINC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATECAlphatec$12.45-0.2%$11.06$4.88▼$13.14$1.82B1.062.04 million shs1.30 million shsLCAPLionheart Acquisition Co. II$25.37-0.9%$10.38$8.94▼$11.70$468.20M0.08102,067 shs1,561 shsLMATLeMaitre Vascular$81.40+2.9%$84.19$71.42▼$109.58$1.84B0.86167,047 shs205,755 shsPINCPremier$23.06-0.6%$20.48$17.23▼$23.56$1.90B0.541.25 million shs1.19 million shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATECAlphatec0.00%-3.94%+9.21%+17.34%+15.71%LCAPLionheart Acquisition Co. II-0.90%-2.55%+6.38%+910.81%+3,423.79%LMATLeMaitre Vascular0.00%-3.98%-11.29%-18.29%+1.72%PINCPremier0.00%-0.26%+15.36%+23.91%+19.36%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationATECAlphatec4.026 of 5 stars3.41.00.03.32.94.20.6LCAPLionheart Acquisition Co. IIN/AN/AN/AN/AN/AN/AN/AN/ALMATLeMaitre Vascular2.6041 of 5 stars2.32.03.30.02.02.51.3PINCPremier2.0293 of 5 stars1.02.02.50.03.62.51.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATECAlphatec 2.89Moderate Buy$17.8943.69% UpsideLCAPLionheart Acquisition Co. II 0.00N/AN/AN/ALMATLeMaitre Vascular 2.63Moderate Buy$98.1420.57% UpsidePINCPremier 2.00Hold$22.20-3.73% DownsideCurrent Analyst Ratings BreakdownLatest LCAP, LMAT, ATEC, and PINC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/21/2025PINCPremierPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$19.00 ➝ $24.005/15/2025PINCPremierRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$19.00 ➝ $22.005/8/2025PINCPremierCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$19.00 ➝ $22.005/2/2025ATECAlphatecPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$13.00 ➝ $15.005/2/2025ATECAlphatecNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$16.00 ➝ $16.004/14/2025ATECAlphatecHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$20.00 ➝ $20.002/28/2025LMATLeMaitre VascularLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$105.00 ➝ $110.002/28/2025LMATLeMaitre VascularOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform2/28/2025LMATLeMaitre VascularBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Market Perform2/27/2025ATECAlphatecPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$12.00 ➝ $13.002/27/2025ATECAlphatecNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$16.00 ➝ $16.00(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATECAlphatec$642.27M2.83N/AN/A$0.57 per share21.84LCAPLionheart Acquisition Co. IIN/AN/A$1.23 per share20.64($2.85) per shareN/ALMATLeMaitre Vascular$226.26M8.13$1.44 per share56.52$13.38 per share6.08PINCPremier$1.26B1.51$4.43 per share5.20$18.81 per share1.23Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATECAlphatec-$186.64M-$1.15N/AN/AN/A-31.06%-541.39%-22.99%7/30/2025 (Estimated)LCAPLionheart Acquisition Co. II$3.21MN/A0.00∞N/AN/A-44.30%1.39%N/ALMATLeMaitre Vascular$30.10M$1.9844.4837.512.2219.40%13.15%11.47%8/7/2025 (Estimated)PINCPremier$119.54M$0.57N/A17.34N/A-0.40%9.41%5.38%N/ALatest LCAP, LMAT, ATEC, and PINC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/1/2025Q1 2025ATECAlphatec-$0.12-$0.35-$0.23-$0.35$167.57 million$169.18 million5/1/2025Q1 2025LMATLeMaitre Vascular$0.50$0.48-$0.02$0.48$57.61 million$59.87 million2/27/2025Q4 2024LMATLeMaitre Vascular$0.49$0.49N/A$0.49$55.99 million$55.81 million2/26/2025Q4 2024ATECAlphatec-$0.19-$0.23-$0.04-$0.23$172.74 million$176.79 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthATECAlphatecN/AN/AN/AN/AN/ALCAPLionheart Acquisition Co. IIN/AN/AN/AN/AN/ALMATLeMaitre Vascular$0.800.98%+13.30%40.40%14 YearsPINCPremier$0.843.64%+2.50%147.37%N/ALatest LCAP, LMAT, ATEC, and PINC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/24/2025PINCPremierquarterly$0.214.2%5/30/20256/1/20256/15/20254/29/2025LMATLeMaitre Vascularquarterly$0.201%5/15/20255/15/20255/29/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioATECAlphatec30.212.321.15LCAPLionheart Acquisition Co. IIN/A0.050.05LMATLeMaitre VascularN/A7.745.52PINCPremierN/A0.830.83Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATECAlphatec66.35%LCAPLionheart Acquisition Co. IIN/ALMATLeMaitre Vascular84.64%PINCPremier74.41%Insider OwnershipCompanyInsider OwnershipATECAlphatec22.80%LCAPLionheart Acquisition Co. II19.40%LMATLeMaitre Vascular9.50%PINCPremier0.96%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATECAlphatec700146.17 million109.48 millionOptionableLCAPLionheart Acquisition Co. II318.45 million14.87 millionNot OptionableLMATLeMaitre Vascular49022.59 million20.06 millionOptionablePINCPremier2,60082.34 million90.43 millionOptionableLCAP, LMAT, ATEC, and PINC HeadlinesRecent News About These CompaniesPremier (NASDAQ:PINC) Stock Price Expected to Rise, Piper Sandler Analyst SaysMay 23 at 11:14 AM | marketbeat.comPremier, Inc. (NASDAQ:PINC) Shares Sold by Bank of America Corp DEMay 23 at 3:17 AM | marketbeat.comWBI Investments LLC Buys Shares of 21,398 Premier, Inc. (NASDAQ:PINC)May 22 at 5:42 AM | marketbeat.comDeutsche Bank AG Purchases 140,367 Shares of Premier, Inc. (NASDAQ:PINC)May 22 at 3:53 AM | marketbeat.comBNP Paribas Financial Markets Acquires 46,302 Shares of Premier, Inc. (NASDAQ:PINC)May 21, 2025 | marketbeat.comOccudo Quantitative Strategies LP Purchases Shares of 10,825 Premier, Inc. (NASDAQ:PINC)May 20, 2025 | marketbeat.comLazard Asset Management LLC Grows Stock Position in Premier, Inc. (NASDAQ:PINC)May 20, 2025 | marketbeat.comEthic Inc. Buys Shares of 11,746 Premier, Inc. (NASDAQ:PINC)May 20, 2025 | marketbeat.comPINC Q1 Earnings Call: Revenue Tops Estimates Amid Tariff and Margin PressuresMay 19, 2025 | msn.comQuantinno Capital Management LP Boosts Holdings in Premier, Inc. (NASDAQ:PINC)May 18, 2025 | marketbeat.comPremier (NASDAQ:PINC) Price Target Raised to $22.00May 18, 2025 | americanbankingnews.comRedwood Investment Management LLC Makes New $3.66 Million Investment in Premier, Inc. (NASDAQ:PINC)May 17, 2025 | marketbeat.comNorthern Trust Corp Has $15.73 Million Stake in Premier, Inc. (NASDAQ:PINC)May 17, 2025 | marketbeat.comShould Value Investors Buy Premier (PINC) Stock?May 16, 2025 | zacks.comPremier’s 15 Top Health Systems for 2025May 15, 2025 | msn.comSaint Joseph Health recognized as a Top 15 Health SystemMay 15, 2025 | lanereport.comPremier Announces the Nation’s 15 Top Health Systems®May 15, 2025 | finance.yahoo.comPremier Announces the Nation's 15 Top Health Systems®May 15, 2025 | businesswire.comHealthcare Technology for Providers Stocks Q1 Earnings Review: Premier (NASDAQ:PINC) ShinesMay 14, 2025 | msn.comThe Strong Earnings Posted By Premier (NASDAQ:PINC) Are A Good Indication Of The Strength Of The BusinessMay 14, 2025 | finance.yahoo.comPremier, Inc. named as data source in HealthVerity Marketplace™ to expand real-world data access for life sciences researchMay 13, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLCAP, LMAT, ATEC, and PINC Company DescriptionsAlphatec NASDAQ:ATEC$12.45 -0.03 (-0.24%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$12.72 +0.28 (+2.21%) As of 05/23/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.Lionheart Acquisition Co. II NASDAQ:LCAPLionheart Acquisition Corporation II does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in PropTech sector. The company was incorporated in 2019 and is based in Miami, Florida.LeMaitre Vascular NASDAQ:LMAT$81.40 +2.28 (+2.88%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$81.47 +0.07 (+0.09%) As of 05/23/2025 04:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.Premier NASDAQ:PINC$23.06 -0.14 (-0.60%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$23.06 0.00 (0.00%) As of 05/23/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services; and STOCKD, an e-commerce platform, as well as direct sourcing business; SaaS informatics products; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is based in Charlotte, North Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain These ETFs Provide Easy Exposure to Growing International Markets Advance Auto Parts Jumps on Surprise Earnings Beat Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
